Oral Dosage Innovation for Pediatric Drug Delivery

Pediatric drug development isn’t just about reducing adult doses. It involves unique technical, regulatory, and manufacturing challenges that require creative formulation strategies. In this webinar, experts from AustinPx and Via Therapeutics explore the complex development of clofazimine mini-tablets for pediatric use, covering solubility issues, stability hurdles, and process optimization from early formulation through clinical manufacturing.

Learn how advanced tools and a data-driven approach helped overcome formulation and scale-up barriers to create a patient-friendly, globally deployable treatment.

Speakers:
Dr. Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dr. Zach Warnken, PhD, Director, Pharmaceutical Development, Via Therapeutics